| scholarly article | Q13442814 |
| P50 | author | Caterina Rosano | Q51929723 |
| Lewis Kuller | Q88077314 | ||
| P2093 | author name string | Rhobert W Evans | |
| Timothy M Hughes | |||
| P2860 | cites work | Alzheimer's disease as homeostatic responses to age-related myelin breakdown | Q22251261 |
| Statins for the treatment of dementia | Q24236484 | ||
| Statins for the prevention of dementia | Q24241335 | ||
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 | ||
| The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol | Q27679405 | ||
| Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism | Q28203757 | ||
| On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells | Q28204125 | ||
| Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease | Q28216782 | ||
| Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry | Q33430870 | ||
| Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study | Q34039786 | ||
| 27-Hydroxycholesterol: the first identified endogenous SERM | Q34762182 | ||
| Linking lipids to Alzheimer's disease: cholesterol and beyond | Q35875480 | ||
| Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease. | Q35947072 | ||
| Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. | Q36658177 | ||
| Liquid chromatography-tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol | Q36924329 | ||
| Oxysterols as markers of neurological disease--a review | Q37387107 | ||
| Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis | Q37402902 | ||
| Cyp46 polymorphisms in Alzheimer's disease: a review | Q37586200 | ||
| Lipids in Alzheimer's disease: A century-old story | Q37752946 | ||
| Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals | Q40146600 | ||
| High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. | Q40541341 | ||
| Cholesterol and myelin. | Q41413832 | ||
| 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. | Q42491801 | ||
| Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. | Q43578320 | ||
| 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia | Q43832865 | ||
| Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. | Q43854094 | ||
| Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain | Q43885523 | ||
| Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls | Q43975879 | ||
| Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis | Q44182504 | ||
| Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide | Q44187794 | ||
| Serum cholesterol, precursors and metabolites and cognitive performance in an aging population | Q44257044 | ||
| Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. | Q44300030 | ||
| Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients | Q44522300 | ||
| Combination of serum markers related to several mechanisms in Alzheimer's disease | Q44555806 | ||
| Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease | Q44605268 | ||
| Diagnostic use of cerebral and extracerebral oxysterols | Q44827953 | ||
| Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? | Q45047113 | ||
| Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients | Q45056703 | ||
| Determination of oxysterols in oxidatively modified low-density lipoprotein by semi-micro high-performance liquid chromatography with electrochemical detection. | Q45947779 | ||
| Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. | Q45949729 | ||
| The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins | Q46563544 | ||
| Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. | Q46689173 | ||
| Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? | Q46889496 | ||
| Total cholesterol and oxysterols: early markers for cognitive decline in elderly? | Q46987252 | ||
| Transport of side-chain oxidized oxysterols in the human circulation | Q47961810 | ||
| High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels | Q48482843 | ||
| Cholesterol synthesis rate in human hippocampus declines with aging. | Q48538995 | ||
| Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms | Q48690631 | ||
| Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. | Q48958887 | ||
| Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. | Q53236302 | ||
| Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. | Q53343318 | ||
| Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders. | Q53388581 | ||
| Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry | Q59307017 | ||
| Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients | Q73462725 | ||
| Statin therapy in the treatment of Alzheimer disease: what is the rationale? | Q81631120 | ||
| P433 | issue | 4 | |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 891-911 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Brain cholesterol metabolism, oxysterols, and dementia | |
| P478 | volume | 33 |
| Q38335068 | 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival |
| Q92017867 | 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone |
| Q36323801 | 24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation |
| Q92572647 | 7-Ketocholesterol in disease and aging |
| Q37739423 | A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus |
| Q35642924 | A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid. |
| Q33853002 | Associations between serum cholesterol levels and cerebral amyloidosis |
| Q38102606 | Autophagy modulation for Alzheimer's disease therapy |
| Q30983556 | Cardiovascular Risk Factors Associated with Smaller Brain Volumes in Regions Identified as Early Predictors of Cognitive Decline |
| Q90146208 | Cholesterol and Dementia: A Long and Complicated Relationship |
| Q38155118 | Cholesterol as a co-solvent and a ligand for membrane proteins |
| Q38719589 | Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis. |
| Q90788733 | Disentangling the genetic overlap between cholesterol and suicide risk |
| Q37019881 | Elevated levels of serum cholesterol are associated with better performance on tasks of episodic memory |
| Q38734322 | Esterification of 24S-OHC induces formation of atypical lipid droplet-like structures, leading to neuronal cell death |
| Q59128127 | Heme Oxygenase-1 and Brain Oxysterols Metabolism Are Linked to Egr-1 Expression in Aged Mice Cortex, but Not in Hippocampus |
| Q30406139 | Markers of cholesterol transport are associated with amyloid deposition in the brain. |
| Q37669838 | Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients |
| Q27023315 | Oxidized cholesterol as the driving force behind the development of Alzheimer's disease |
| Q90230131 | Oxysterols in Autoimmunity |
| Q37653212 | Plasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C. |
| Q42363936 | Predicting the multi-domain progression of Parkinson's disease: a Bayesian multivariate generalized linear mixed-effect model |
| Q37325631 | Relationship between oxysterols and mild cognitive impairment in the elderly: a case-control study |
| Q50532647 | The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease. |
Search more.